Wave Life Sciences (WVE) Times Interest Earned (2014 - 2026)

Wave Life Sciences' (WVE) quarterly Times Interest Earned came in at -$1800.0 in Q2 2026, down 2134365.18% on a QoQ basis from $0.08 in Q4 2024.

Wave Life Sciences (WVE) Times Interest Earned (2014 - 2026) Analysis & Trends

Wave Life Sciences (WVE) has 12 years of Times Interest Earned data on file, last reported at -$1800.0 in Q2 2026.

Quarterly Times Interest Earned changed N/A year-over-year to -$1800.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$5315.1 (changed N/A YoY) and the FY2025 annual result came in at -$0.66, down 62.62% from the prior year.
Times Interest Earned declined to -$1800.0 in Q2 2026, from $0.08 in the prior quarter.
In the past five years, Times Interest Earned ranged from a high of $0.08 in Q4 2024 to a low of -$1800.0 in Q2 2026.
A 4-year average of -$450.06 and a median of -$0.13 in 2022 frame the typical range for Times Interest Earned.
Annual changes were most pronounced in 2022 — Times Interest Earned slipped 26.98% — and 2024, when it surged 211.6%.
Tracing WVE's Times Interest Earned over 4 years: stood at -$0.19 in 2022, then surged by 60.74% to -$0.08 in 2023, then soared by 211.6% to $0.08 in 2024, then sank by 2134365.18% to -$1800.0 in 2026.
The last three Times Interest Earned figures came in at -$1800.0 (Q2 2026), $0.08 (Q4 2024), and -$0.08 (Q4 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	2.84
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	24.64
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-0.19
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	8.18
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-0.01
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.61
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	2.82
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-0.08
10	Wave Life Sciences	1.05 Bn	677.62 Mn	-	-1,800.05

Download Data